A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis Meeting Abstract
| Authors: | Gounder, M. M.; Zer, A.; Tap, W. D.; Gupta, A. A.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Chi, P.; Tanner, L. R.; Konen, T.; Rashal, T.; McCauley, D.; Saint-Martin, J. R.; Carlson, R.; Marshall, T.; Shacham, S.; Mirza, M. R.; Kauffman, M.; Schwartz, G.; Razak, A. R. A. |
| Abstract Title: | A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036900209 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.10569 |
| Notes: | Meeting Abstract: 10569 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
